AUSTIN, TEXAS, Lifasyst Technologies CEO Georgios Mihos attended the 47th Annual Conference of the Association of Avian Veterinarians (AAV) in Austin, Texas, alongside consulting veterinarian and Veterinary Advisory Board member, Dr Matt Gosbell Director of Melbourne Bird Veterinary Clinic, who presented the benefits of the company’s Australian-developed Vetasyst® technology.
Held at the Renaissance Hotel from 2–5 October, the conference provided an opportunity to connect with veterinary professionals from across the United States and around the world, showcasing an innovative approach to medication preparation and delivery for animals.
Dr Gosbell presented the advantages of Vetasyst® UltrasonIQ® technology compared with traditional medication crushing methods, highlighting its ability to produce a fine, evenly distributed particle size to support medication compounding and administration across a range of species, including birds, reptiles and mammals.
The strong engagement and encouraging enquiries from across the USA reflect growing interest in practical solutions that can help make medication preparation and delivery easier for veterinary professionals and the animals in their care.
Vetasyst is part of Lifasyst® Technologies’ broader vision to transform medication delivery across both animal and human healthcare, alongside its human-care division, Medasyst®.
From Australia to the United States and beyond, Lifasyst Technologies remains committed to developing HealthTech innovations that address real-world challenges and make a meaningful difference to the lives of people and animals.
Changing the way medications are delivered, for people and animals alike.
For further information please email info@vetasyst.com.au